Efficient Semisynthesis of a Tetraphosphorylated Analogue of the Type I TGFβ ReceptorRobert R. Flavell, Tom W. Muir, Morgan Huse et al.|Organic Letters|2001Cited by 55
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with<sup>18</sup>F-FDGBrad Kline, Thomas A. Hope, Jessa B. Castillo et al.|Journal of Nuclear Medicine|2024Cited by 36
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5Kondapa Naidu Bobba, Robert R. Flavell|Theranostics|2024Cited by 27
Treatment of prostate cancer with CD46 targeted <sup>225</sup> Ac alpha particle radioimmunotherapyAnil P. Bidkar, Robert R. Flavell|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0